Global Haemoglobin A1c Testing Market Size, Share, Forecast Report, 2020-2027

The global Haemoglobin A1c Testing market garnered revenue around USD 1,676.4 million in 2019 and projected to reach USD 4,117.8 million in 2027, with at a compound annual growth rate (CAGR) 10.8% throughout the estimate period from 2020 to 2027.

Hemoglobin A1c testing devices are used to determine and monitor hemoglobin A1c levels in diabetic patients. For more than 500 million people affected with diabetes across the world, blood testing has become a routine part of managing the disease. A1C tests measure average blood glucose over the past two to three months. It is also known as glycosylated hemoglobin test, glycohemoglobin test, glycated hemoglobin test, or A1C.

In terms of technology, ion-exchange HPLC segment dominated the market owing to the establishment of this technology as gold standard method of determination of HbA1c due to its excellent specificity and reproducibility. A clinical study by the company indicated that 205 patients with SC and diabetes were analyzed using immunoassay and HPLC instrument. The immunoassay study produced lower HBA1c compared to HPLC method.

In terms of end-user, hemoglobin A1c testing devices are mostly used in laboratories and point-of-care units such as hospitals, clinics, home care, and others.

 North America dominated the global Hemoglobin A1c Testing Devices market in 2019 and the trend is anticipated to continue during the forecast period. High prevalence of different types of diabetes and rise in the geriatric population in the region are some of the factors augmenting the market in North America are expected to drive the market in North America.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Hemoglobin A1c Testing market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Hemoglobin A1c Testing market growth.

The global Hemoglobin A1c Testing market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

Key players in the global market include Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, Trinity Biotech plc. and other prominent players.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

• Global Hemoglobin A1c Testing Devices  Market, by Technology
  • Ion-exchange High Performance Liquid Chromatography (HPLC)
  • Immunoassay
  • Boronate Affinity Chromatography
  • Direct Enzymatic Assay
  • Others (micro-optical detection method, and capillary electrophoresis)
• Global Hemoglobin A1c Testing Devices  Market, by End-user
  • Laboratories
    • Commercial Laboratories
    • Others (private research labs, university labs, testing labs, etc.)
  • Point-of-Care (POC) Setting
    • Hospitals
    • Home Care
    • Clinics
    • Others (physician offices, etc.)

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA